Clinical and hematologic features of 300 patients affected by hereditary spherocytosis grouped according to the type of the membrane protein defect

Haematologica

Volumn 93, Issue 9, 2008, Pages 1310-1317

  Mariani, Mariagabriella ^a   Barcellini, Wilma ^a   Vercellati, Cristina ^a   Marcello, Anna Paola ^a   Fermo, Elisa ^a   Pedotti, Paola ^a   Boschetti, Carla ^a   Zanella, Alberto ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Erythrocyte membrane; Hereditary spherocytosis; Protein deficiencies; SDS PAGE; Splenectomy

Indexed keywords

ANKYRIN; DODECYL SULFATE SODIUM; ERYTHROCYTE BAND 3 PROTEIN; SPECTRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; FEMALE; HEREDITARY SPHEROCYTOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEFICIENCY; SENSITIVITY ANALYSIS; SPLENECTOMY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MEMBRANE PROTEINS; MIDDLE AGED; SPHEROCYTOSIS, HEREDITARY; SPLENECTOMY;

EID: 50849126820     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12546     Document Type: Article

References (53)

1. Morton NE, MacKinney AA, Kosower N. Genetics of spherocytosis. Am J Hum Gen 1962;14:170-8.
2. Godal HC, Heisto H. High prevalence of increased osmotic fragility of red blood cells among Norwegian blood donors. Scand J Haematol 1981;27:30-4.
3. Tse WT, Lux SE. Red blood cell membrane disorders. Br J Haematol 1999;104:2-13.
4. Eber SW, Pekrun A, Neufeldt A, Schroter W. Prevalence of increased osmotic fragility of erythrocytes in German blood donors: screening using a modified glycerol lysis test. Ann Hematol 1992;64:88-92.
5. Delaunay J. The molecular basis of hereditary red cell membrane disorders. Blood Rev 2007;21:1-20.
6. Eber SW, Ambrust R, Schroeter W. Variable clinical severity of hereditary spherocytosis: relation to erythrocytic spectrin concentration, osmotic fragility, and autohemolysis. J Pediatr 1990;117:409-16.
7. Miraglia del Giudice E, Nobili B, Francese M, D'Urso L, Iolascon A, Eber S, et al. Clinical and molecular evaluation of non-dominant hereditary spherocytosis. Br J Haematol 2001;112:42-7.
8. Hassoun H, Palek J. Hereditary spherocytosis: a review of the clinical and molecular aspects of the disease. Blood Rev 1996;10:129-47.
9. Gallagher PG. Red cell membrane disorders. Hematology. American Society of Hematology, Educational Program 2005.
10. Maillet P, Alloisio N, Morlè L, Delaunay J. Spectrin mutation in hereditary elliptocytosis and hereditary spherocytosis. Hum Mutat 1996;8:97-100.
11. Gallagher PG, Forget BG. Hematologically important mutations: band 3 and protein 4.2 variants in hereditary spherocytosis. Blood Cell Mol Dis 1997;23:417-21.
12. Gallagher PG, Sabatino DE, Basseres DS, Nilson DM, Wong C, Cline AP, et al. Erythrocyte ankyrin promoter mutations associated with recessive hereditary spherocytosis cause significant abnormalities in ankyrin expression. J Biol Chem 2001;276: 41683-9.
13. Cooper RA, Jandl JH. The role of membrane lipids in the survival of red cells in hereditary spherocytosis. J Clin Invest 1969;48:736-44.
14. Da Costa L, Mohandas N, Sorette M, Grange MJ, Tchernia G, Cynober T. Temporal differences in membrane loss lead to distinct reticulocyte features in hereditary spherocytosis and in immune hemolytic anemia. Blood 2001;98:2894-9.
15. Miraglia del Giudice E, Iolascon A, Pinto L, Nobili B, Perrotta S. Erythrocyte membrane protein alterations underlying clinical heterogeneity in hereditary spherocytosis. Br J Haematol 1994;88:52-5.
16. Jarolim P, Murray JL, Rubin HL, Taylor WM, Prchal JT, Ballas SK, et al. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood 1996;88:4366-74.
17. Cynober T, Mohandas N, Tchernia G. Red cell abnormalities in hereditary spherocytosis: relevance to diagnosis and understanding of the variable expression of clinical severity. J Lab Clin Med 1996;12:259-69.
18. Ricard MP, Gilsanz F, Millan I. Erythroid membrane protein defects in hereditary spherocytosis. A study of 62 Spanish cases. Haematologica 2000;85:994-5.
19. Lee YK, Cho HI, Park SS, Lee YJ, Ra E, Chang YH, et al. Abnormalities of erythrocyte membrane proteins in Korean patients with hereditary spherocytosis. J Kor Med Sci 2000;15:284-8.
20. Yawata Y, Kanzaki A, Yawata A, Doerfler W, Ozcan R, Eber S. Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population. Int J Hematol 2000;71:118-35.
21. Agre P, Asimos A, Casella JF, McMillan C. Inheritance pattern and clinical response to splenectomy as a reflection of erythrocyte spectrin deficiency in hereditary spherocytosis. N Engl J Med 1986;315:1579-83.
22. Nakanishi H, Kanzaki A, Yawata A, Yamada O, Yawata Y. Ankyrin gene mutations in Japanese patients with hereditary spherocytosis. Int J Hematol 2001;73:54-63.
23. Reliene R, Mariani M, Zanella A, Reinhart WH, Ribeiro L, Miraglia del Giudice E, et al. Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin-and band 3- deficient hereditary spherocytosis. Blood 2002;100:2208-15.
24. Marchetti M, Quaglini S, Barosi G. Prophylactic splenectomy and cholecystectomy in mild hereditary spherocytosis: analyzing the decision in different clinical scenarios. J Int Med 1998;244:217-26.
25. Bolton-Maggs PHB, Stevens RF, Dodd NJ, Lamont G, Tittensor P, King MJ. Guidelines for the diagnosis and management of hereditary spherocytosis. Br J Haematol 2004; 126:455-74.
26. Sirchia G. Il sistema sangue. Centro Trasfusionale Ospedale Maggiore Policlinico di Milano, 1983.
27. th edition. W.B: Saunders Company 1998.
28. Parpart AK, Lorenz PB, Parpart ER, Gregg JR, Chase AN. The osmotic resistance (fragilities) of human red cells. J Clin Invest 1947;26:636-45.
29. Gottfried EL, Robertson MA. Glycerol lysis time as a screening test for erythrocyte disorders. J Lab Clin Med 1974;83:323-33.
30. Zanella A, Izzo C, Rebulla P, Zanuso F, Perroni L, Sirchia G. Acidified glycerol lysis test (AGLT): a screening test for spherocytosis. Br J Haematol 1980;45:481-6.
31. Vettore L, Zanella A, Molaro GL, De Matteis MC, Pavesi M, Mariani M. A new test for the laboratory diagnosis of spherocytosis. Acta Haematologica 1984;72:258-63.
32. Streichman S, Gesheidt Y, Tatarski I. Hypertonic cryohemolysis: a diagnostic test for hereditary spherocytosis. Am J Hematol 1990;35:104-9.
33. King MJ, Behrens J, Rogers C, Flynn C, Greenwood D, Chambers K. Rapid flow cytometric test for the diagnosis of membrane cytoskeleton-associated haemolytic anaemia. Br J Haematol 2000;111:924-33.
34. Zanella A, Fermo E, Bianchi P, Valentini G. Red cell pyruvate kinase deficiency: molecular and clinical aspects. Br J Haematol 2005; 130:11-25.
35. Beutler E. Red Cell Metabolism: A Manual of Biochemical Methods. New York, NY: Grune and Stratton, Inc. 1984.
36. Dodge JT, Mitchell C, Hanahan DJ. The preparation and chemical characteristics of hemoglobin free ghosts of human erythrocytes. Arch Biochem Biophys 1963;100:119-30.
37. Beutler E, West C, Blume KG. The removal of leukocytes and platelets from whole blood. J Lab Clin Med 1976;88:328-33.
38. Lutz UH, Wipf G. Naturally occurring autoantibodies to skeletal proteins from human red blood cells. J Immunol 1982;128:1695-9.
39. Fairbanks G, Steck TL, Wallach DFH. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 1971;10:2606-17.
40. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
41. 2 and the problem of small samples. Mol Biol Evol 1989;6:539-45.
42. nd edition, Lippincott Williams and Wilkins, 2003.
43. Rocha S, Rebelo I, Costa E, Catarino C, Belo L, Castro EBM, et al. Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis. Eur J Haematol 2005;74:374-80.
44. Lanciotti M, Perutelli P, Valetto A, Di Martino D, Mori PG. Ankyrin deficiency is the most common defect in dominant and non dominant hereditary spherocytosis. Haematologica 1997;82:460-2.
45. Dhermy D, Bournier O, Bourgeois M, Grandchamp B. The red blood cell band 3 variant (band 3 Bicetrel: R 490C) association with dominant hereditary spherocytosis causes defective membrane targeting of the molecule and a dominant negative effect. Mol Membr Biol 1999;16:305-12.
46. Premetis E, Stamoulakatou A, Loukopoulos D. Hereditary spherocytosis in Greece: collective data on a large number of patients. Hematology 1999;4:361-6.
47. Sanchez-Lopez JY, Camacho AL, Magana MT, Ibarra B, Perea FJ. Red cell membrane protein deficiencies in Mexican patients with hereditary spherocytosis. Blood Cells Mol Dis 2003;31:357-9.
48. Saad STO, Costa FF, Vicentim DL, Salles TSI, Pranke PHL. Red cell membrane protein abnormalities in hereditary spherocytosis in Brazil. Br J Haematol 1994;88:295-9.
49. Jarolim P, Brabec V, Ballas SK, Prchal JT, Poon MC, Castleberry R, et al. Biochemical heterogeneity of the hereditary spherocytosis syndrome (abstract). Paper presented at the 24th Congress of the International Society of Haematology, London, 1992.
50. Pinto L, Iolascon A, Miraglia del Giudice E, Matarese S, Nobili B, Perrotta S. The Italian pediatric survey on hereditary spherocytosis. Int J Pediatr Hematol/Oncol 1995; 2:43-7.
51. Michaels LA, Cohen AR, Zhao H, Raphael RI, Manno CS. Screening for hereditary spherocytosis by use of automated erythrocyte indexes. J Pediatr 1997;130:957-60.
52. Krueger HC, Burgert EO Jr. Hereditary spherocytosis in 100 children. Mayo Clin Proc 1966;41:821-30.
53. Mariani M, Vercellati C, Bianchi P, Marzorati S, Caneva L, Soligo C, et al. Congenital dyserythropoietic anemia type II (CDA II) mimicking hereditary spherocytosis (HS): report of 12 cases detected by SDS-PAGE. Hematol J 2002;3:353. (abstract).